"Comprehensive Outlook on Executive Summary Europe Next Generation Sequencing (NGS) Market Size and Share

CAGR Value 

Europe next generation sequencing (NGS) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 15.7% in the forecast period of 2022 to 2029 and is expected to reach USD 8,733.08 million by 2029.

Europe Next Generation Sequencing (NGS) Market research report is generated with the best and advanced tools of collecting, recording, estimating and analyzing market data. With the systematic and comprehensive market research study, this market research report provides the facts associated with any subject in the field of marketing for Europe Next Generation Sequencing (NGS) Market industry. It gives better ideas and solutions in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviours. This Europe Next Generation Sequencing (NGS) Market report has been prepared by considering several fragments of the present and upcoming market scenario.

This Europe Next Generation Sequencing (NGS) report not only provides market segmentation in the most detailed pattern but also conducts thorough analysis of patents and major market players to provide a competitive landscape. The report provides market data even by considering new product development from beginning to launch. The report discusses the recent and future market trends and performs analysis of the impact of buyers, substitutes, new entrants, competitors, and suppliers on the market. This Europe Next Generation Sequencing (NGS) Market report broadly encompasses absolute and distinct analysis of the market drivers and restraints, major market players involved in this industry, exhaustive analysis of the market segmentation, and competitive analysis of the key players.

Access expert insights and data-driven projections in our detailed Europe Next Generation Sequencing (NGS) Market study. Download full report:
https://www.databridgemarketresearch.com/reports/europe-next-generation-sequencing-ngs-market

Europe Next Generation Sequencing (NGS) Industry Snapshot

Segments

- By Product & Service
- Pre-Sequencing Products & Services
- DNA Fragmentation Systems
- DNA Extraction
- Sample Preparation
- Other Pre-Sequencing Products & Services
- Sequencing Services
- Sequencing Instruments & Consumables
- By Technique
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
- Other Techniques
- By Application
- Diagnostics
- Drug Discovery
- Biomarker Discovery
- Personalized Medicine
- Agriculture & Animal Research
- Other Applications
- By End User
- Research Centers & Academic/Government Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other End Users

The Europe Next Generation Sequencing (NGS) market is segmented by product & service, technique, application, and end user. In terms of product & service, the market is divided into pre-sequencing products & services, sequencing services, and sequencing instruments & consumables. The technique segment includes sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other techniques. Application-wise, NGS is used in diagnostics, drug discovery, biomarker discovery, personalized medicine, agriculture & animal research, and other applications. Finally, the end user segment comprises research centers & academic/government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users.

Market Players

- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California, Inc.
- BGI
- Agilent Technologies, Inc.
- PerkinElmer Inc.
- Eurofins Scientific
- GATC Biotech AG
- Macrogen, Inc.

Key players in the Europe Next Generation Sequencing market include Illumina, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., BGI, Agilent Technologies, Inc., PerkinElmer Inc., Eurofins Scientific, GATC Biotech AG, and Macrogen, Inc. These companies are at the forefront of innovation and play a significant role in driving advancements in the NGS industry in Europe.

The Europe Next Generation Sequencing (NGS) market is witnessing significant growth driven by technological advancements, increasing applications across various sectors, and growing adoption among end users. Illumina, Inc. stands as a key player in the market, known for its innovative sequencing technologies and widespread market presence. The company's continuous investment in research and development has allowed it to stay ahead of the curve in terms of product offerings and performance. Illumina's sequencing platforms are widely used in research centers, hospitals, and biotech companies for a range of applications such as diagnostics, drug discovery, and personalized medicine.

Thermo Fisher Scientific Inc. is another prominent player in the Europe NGS market, known for its comprehensive portfolio of sequencing instruments and consumables. The company's strong presence in the diagnostics and pharmaceutical sectors has fueled its growth in the region. Thermo Fisher's commitment to providing cutting-edge solutions for researchers and clinicians has solidified its position as a preferred partner in the NGS space.

Oxford Nanopore Technologies has made a mark in the Europe NGS market with its innovative nanopore sequencing technology. This disruptive approach to sequencing has garnered significant interest among researchers and end users looking for portable and real-time sequencing solutions. The company's MinION and PromethION platforms have been pivotal in expanding the applications of NGS in fields such as agriculture, environmental research, and infectious disease surveillance.

Pacific Biosciences of California, Inc. is known for its single-molecule real-time (SMRT) sequencing technology, offering long read lengths and high accuracy for complex genomic analysis. The company's platforms are widely used in genomics research and clinical diagnostics, showcasing the potential of SMRT sequencing in addressing various biological questions.

BGI, a major player in the Europe NGS market, is recognized for its large-scale sequencing capabilities and bioinformatics expertise. The company's focus on genomics research and collaborations with academic institutions have positioned it as a leader in genomic data generation and analysis. BGI's contribution to genomic studies in diverse fields such as agriculture, oncology, and infectious diseases underscores its impact on advancing NGS applications in Europe.

Overall, the Europe NGS market is characterized by intense competition, rapid technological advancements, and a diverse range of applications across sectors. Key players are expected to continue investing in research and development to drive innovation and expand their market presence. With the increasing adoption of NGS technologies in various fields, the market is poised for further growth and evolution in the coming years.The Europe Next Generation Sequencing (NGS) market is experiencing robust growth, fueled by a combination of technological advancements, expanding application areas, and a rising adoption among different end users. Illumina, Inc. stands out as a dominant player in this market, renowned for its cutting-edge sequencing technologies and extensive market reach. The company's continuous focus on research and development enables it to offer innovative products that cater to the diverse needs of research centers, hospitals, and biotech companies across Europe. Illumina's platforms are extensively utilized in diagnostics, drug discovery, and personalized medicine applications, positioning the company as a key contributor to the advancement of NGS technology in the region.

Thermo Fisher Scientific Inc. also holds a significant presence in the Europe NGS market, known for its comprehensive range of sequencing instruments and consumables. The company's strong foothold in the diagnostics and pharmaceutical sectors has been instrumental in driving its growth trajectory in Europe. Thermo Fisher's commitment to delivering state-of-the-art solutions for researchers and clinicians reinforces its role as a trusted partner in the NGS domain, facilitating advancements in sequencing technologies and applications.

Oxford Nanopore Technologies has emerged as a notable player in the Europe NGS market, leveraging its revolutionary nanopore sequencing technology to offer portable and real-time sequencing solutions. The company's MinION and PromethION platforms have garnered considerable interest among researchers seeking advanced sequencing capabilities for applications in agriculture, environmental research, and infectious disease monitoring. Oxford Nanopore Technologies' innovative approach underscores the transformative potential of NGS in diverse fields and highlights the growing importance of portable sequencing solutions in the European market.

Pacific Biosciences of California, Inc. is recognized for its SMRT sequencing technology, renowned for its ability to provide long read lengths and high accuracy for complex genomic analysis. The company's platforms are extensively used in genomics research and clinical diagnostics, showcasing the efficacy of SMRT sequencing in addressing complex biological questions. By offering advanced sequencing solutions, Pacific Biosciences plays a vital role in driving genomic research and expanding the application of NGS technologies in varied sectors across Europe.

BGI is a key player in the Europe NGS market, known for its expertise in large-scale sequencing and bioinformatics. The company's focus on genomics research, coupled with collaborations with academic institutions, has established it as a leader in genomic data generation and analysis. BGI's significant contributions to genomic studies in areas such as agriculture, oncology, and infectious diseases underscore its impact on advancing NGS applications in Europe, emphasizing the critical role of robust data generation and analysis in driving scientific progress and innovation in the region.

In conclusion, the Europe NGS market is characterized by intense competition, rapid technological advancements, and a diverse array of applications spanning multiple sectors. Key players such as Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences of California, and BGI continue to drive innovation, expand their market presence, and shape the future landscape of NGS technology in Europe. With increasing adoption of NGS solutions across various industries and research domains, the market is poised for continued growth and evolution, promising new opportunities for market players to enhance their offerings and address emerging challenges in the genomics landscape.

Discover the company’s competitive share in the industry
https://www.databridgemarketresearch.com/reports/europe-next-generation-sequencing-ngs-market/companies

Market Intelligence Question Sets for Europe Next Generation Sequencing (NGS) Industry

• How big is the current global Europe Next Generation Sequencing (NGS) Market?
• What is the forecasted Europe Next Generation Sequencing (NGS) Market expansion through 2032?
• What core segments are covered in the report on the Europe Next Generation Sequencing (NGS) Market?
• Who are the strategic players in the Europe Next Generation Sequencing (NGS) Market?
• What countries are part of the regional analysis in the Europe Next Generation Sequencing (NGS) Market?
• Who are the prominent vendors in the global Europe Next Generation Sequencing (NGS) Market?

Browse More Reports:

Global Canopy Beds Market
Global Cellulosic Fire Protection Intumescent Coatings Market
Global Ceramic Coating Cookware Market
Global Chewing Gum Coatings Market
Global Composite Cans Market
Global Cone- Rod Dystrophy Market
Global Content Analytics Market
Global Core Needle Biopsy Market
Global Dairy Free Snacks Market
Global Elbow Replacement Orthopedic Devices Market
Global Emulsifiers in Dietary Supplements Market
Global Energy Intelligence Solution Market
Global Enhanced Vision System Market
Global Facial Fat Transfer Market
Global Fatty Acid Esters Market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com

 "